• Publications
  • Influence
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
This International Myeloma Working Group consensus updates the disease definition of multiple myeloma to include validated biomarkers in addition to existing requirements of attributable CRABExpand
  • 1,721
  • 136
  • PDF
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
The analysis of rare chromosomal translocations in myeloproliferative disorders has highlighted the importance of aberrant tyrosine kinase signaling in the pathogenesis of these diseases. Here weExpand
  • 817
  • 46
  • PDF
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.
We conducted a pooled analysis of 869 individual newly diagnosed elderly patient data from 3 prospective trials. At diagnosis, a geriatric assessment had been performed. An additive scoring systemExpand
  • 346
  • 19
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
Several imaging technologies are used for the diagnosis and management of patients with multiple myeloma (MM). Conventional radiography, computed tomography (CT), magnetic resonance imaging (MRI) andExpand
  • 375
  • 16
  • PDF
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
Osteonecrosis of the jaw (ONJ) has been associated with the use of pamidronate and zoledronic acid. ONJ was assessed prospectively since July 2003 in 202 patients with multiple myeloma (MM) whoExpand
  • 317
  • 16
  • PDF
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
The European Myeloma Network provides recommendations for the management of the most common complications of multiple myeloma. Whole body low-dose computed tomography is more sensitive thanExpand
  • 194
  • 15
  • PDF
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.
PURPOSE The aim of International Myeloma Working Group was to develop practical recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma (MM). METHODS AnExpand
  • 223
  • 14
  • PDF
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
These Clinical Practice Guidelines are endorsed by the Japanese Society of Medical Oncology (JSMO) incidence and epidemiology Multiple myeloma (MM) accounts for 1% of all cancers and ∼10% of allExpand
  • 375
  • 13
  • PDF
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).
The aim of this prospective study was to evaluate the long-term efficacy and safety of hydroxyurea (HU) in patients with sickle cell disease (SCD). Thirty-four patients with sickle cell anemiaExpand
  • 313
  • 13
  • PDF
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
For patients with bone metastases, high N‐telopeptide of type I collagen (NTX) levels correlate with increased risks of skeletal‐related events and death. However, the relation between NTX decreasesExpand
  • 234
  • 12